Follow
Elda Railey
Elda Railey
Research Advocacy Network
Verified email at researchadvocacy.org
Title
Cited by
Cited by
Year
Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199
BP Schneider, L Li, M Radovich, F Shen, KD Miller, DA Flockhart, G Jiang, ...
Clinical Cancer Research 21 (22), 5082-5091, 2015
1432015
Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.
BP Schneider, L Li, K Miller, D Flockhart, M Radovich, BA Hancock, ...
Journal of Clinical Oncology 29 (15_suppl), 1000-1000, 2011
582011
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
BP Schneider, L Li, F Shen, KD Miller, M Radovich, A O'neill, RJ Gray, ...
British journal of cancer 111 (6), 1241-1248, 2014
502014
Examining and predicting drug preferences of patients with metastatic breast cancer: using conjoint analysis to examine attributes of paclitaxel and capecitabine
ML Smith, CB White, E Railey, GW Sledge
Breast cancer research and treatment 145, 83-89, 2014
202014
Tumor genomic profiling practices and perceptions: a survey of physicians participating in the NCI-match trial
A Chen, K Flaherty, PJ O’Dwyer, B Giantonio, DM Marinucci, JW Lee, ...
JCO precision oncology 4, 1207-1216, 2020
112020
Discerning the clinical relevance of biomarkers in early stage breast cancer
TJ Ballinger, N Kassem, F Shen, G Jiang, ML Smith, E Railey, J Howell, ...
Breast cancer research and treatment 164, 89-97, 2017
92017
Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology
MS von Itzstein, E Railey, ML Smith, CB White, GW Sledge Jr, JR Howell, ...
Cancer 126 (8), 1605-1613, 2020
72020
Examining patient choices for metastatic breast cancer drugs.
ML Smith, CB White, E Railey, AM Storniolo, GW Sledge
Journal of Clinical Oncology 30 (15_suppl), 6053-6053, 2012
52012
Preferences of patients with metastatic breast cancer.
ML Smith, CB White, E Railey, AM Storniolo, GW Sledge
Journal of Clinical Oncology 29 (15_suppl), 6044-6044, 2011
52011
Accessing targeted therapies: a potential roadblock to implementing precision oncology?
MS von Itzstein, ML Smith, E Railey, CB White, JS Dieterich, ...
JCO Oncology Practice 17 (7), e999-e1011, 2021
42021
NGS testing use and results: A survey of US oncologists.
ML Smith, E Railey, CB White, JS Dieterich, E Garrett-Mayer, ...
Journal of Clinical Oncology 38 (15_suppl), e19145-e19145, 2020
22020
Use, attitudes, and perceptions of tumor genomic testing: Survey of TAPUR physicians.
SS Bruinooge, AC Dueck, SW Gray, NL Butler, CB White, ML Smith, ...
Journal of Clinical Oncology 37 (15_suppl), 6531-6531, 2019
22019
Do informed patients have different CIPN outcomes? Results of a Research Advocacy Network survey.
ML Smith, CB White, E Railey, R Bellucci, C Thompson
Journal of Clinical Oncology 34 (7_suppl), 60-60, 2016
12016
Discerning clinical relevance of biomarkers in early stage breast cancer
ML Smith, E Railey, CB White, BP Schneider
Infection 5, 5, 2013
12013
Abstract PO4-03-11: Discerning the impact of ctDNA detection on patient decisions in early-stage breast cancer
T Ballinger, G Zimet, E Railey, ML Smith, B Schneider
Cancer Research 84 (9_Supplement), PO4-03-11-PO4-03-11, 2024
2024
New insights on oncologist use of genomic testing.
ML Smith, CB White, E Railey, SW Gray, DE Gerber
Journal of Clinical Oncology 41 (16_suppl), e18741-e18741, 2023
2023
Abstract P5-15-07: Let's talk about it: Communicating about risk of recurrence in early-stage breast cancer
ML Smith, EM Railey, CB White
Cancer Research 82 (4_Supplement), P5-15-07-P5-15-07, 2022
2022
Abstract PS9-01: Consumer and patient reactions to trials of chemotherapy reductions reveal an urgent need to name and explain the concept
ML Smith, E Railey, CB White, J Hill, CJ Andrews, GB Rocque
Cancer Research 81 (4_Supplement), PS9-01-PS9-01, 2021
2021
The influence of patient engagement on the design and implementation of a clinical trial to improve cancer care delivery.
S Barger, SD Sullivan, GH Lyman, DL Hershman, A Bell-Brown, ...
Journal of Clinical Oncology 36 (30_suppl), 223-223, 2018
2018
Do informed patients have different chemotherapy-induced peripheral neuropathy outcomes? Results of research advocacy network's survey
ML Smith, C White, E Railey, R Bellucci, C Thompson, C Chauhan
QUALITY OF LIFE RESEARCH 25, 114-114, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20